EC Microbiology

The importance of viruses and their viromes in disease is fundamental, and we must delve into these aspects if we are interested in managing the microbiome as a modulator in the health of patients we seek. It is important to develop knowledge of the intestinal microbiota, since the interrelationship between viruses and bacteria, as well as with the rest of the microbiome components, is fundamental. This is not easy, as only 1% to 2% of existing viruses have been detected. It is currently not possible to detect all these microorganisms when performing sequencing studies, resulting in a rudimentary viral database. Considerable research is directed toward these tasks, as the enormous impact and large number of viruses have been noted, and the necessary techniques are being sought to contribute to our understanding of viruses, their viromes, and their diverse functions in the microbiome as a whole.

 Keywords: Viroma (Vir); Microbioma (Mic); Irritable Bowel Syndrome (IBS); Intestinal Microbiota (GM); Fecal Microbiota Transplant (FMT)

1. Faith DP and Walker PA. “Environmental diversity: on the best-possible use of Surrogate data for assessing the relative biodiversity of sets of áreas”. Biodiversity and Conservation 5 (1996): 339-415.
2. Beier P and Suzart de Alburquerque F. “Environmental diversity as a surrogate for species representation”. Conservation Biology5 (2015): 1401-1410.
3. Betancourt S and Asencio H. “Homeostasis hombre-naturaleza”. Salutem Scientia Spiritus1 (2016): 51-53.
4. Phillips ML. “Reacción visceral: Efectos ambientales sobre la microbiota humana”. Salud Pública México4 (2009).
5. Joshi YK., et al. “Cleaning of the Singapore river and Kallang Basin in Singapore: Human and environmental dimensions”. Ambio7 (2012): 777-781.
6. Vallès Y and Francino MP. “Air pollution, early life microbiome, and development”. Current Environmental Health Reports 4 (2018): 512-521.
7. Wath SB., et al. “E-waste scenario in India, its management and implications”. Environmental Monitoring and Assessment 172 (2011): 249-262.
8. Kruck A., et al. “What went wrong? the world health organization from swine flu to Ebola”. Political Mistakes and Policy Failures in International Relations 9 (2017): 193-215.
9. World Health Oganization. “Coronavirus disease 2019 (COVID-19) Situation Report-94” (2020).
10. Zou S., et al. “Research on the human virome: where are we and what is next”. Microbiome1 (2016): 32.
11. Liu Q., et al. “Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma”. Gut Pathogens 11 (2019): 1.
12. Domínguez-Díaz C., et al. “Microbiota and its role on viral evasion: is it with us or against us?” Frontiers in Cellular and Infection Microbiology 9 (2019): 256.
13. Carding SR., et al. “Review article: the human intestinal virome in health and disease”. Alimentary Pharmacology and Therapeutics 9 (2017): 800-815.
14. DeBiasi RL and Tyler KL. “Orthoreoviruses and orbiviruses”. Mandell, Douglas, and Bennett´s. Principles and Practice of Infectious Diseases (2015): 1848-1850.e1.
15. Edwards RA., et al. “Computational approaches to predict bacteriophage-host relationships”. FEMS Microbiology Reviews2 (2016): 258-272.
16. Cadwell K. “The virome in host health and disease”. Immunity5 (2015): 805-813.
17. Santiago-Rodríguez TM and Hollister EB. “Human virome and disease: high-throughput sequencing for virus discovery, identification of phage-bacteria dysbiosis and development of therapeutic approaches with emphasis on the human gut”. Viruses7 (2019): 656.
18. Li N., et al. “The commensal microbiota and viral infection: a comprehensive review”. Frontiers in Immunology 10 (2019): 1551.
19. Foxman EF and Iwasaki A. “Genome-virome interactions: examining the role of common viral infections in complex disease”. Nature Reviews Microbiology 4 (2011): 254-264.
20. Neu U and Mainou BA. “Virus interactions with bacteria: Partners in the infectious dance”. PLOS Pathogens2 (2020): e1008234.
21. Shen M., et al. “Intricate transmission routes and Interactions between picorna-like viruses (Kashmir bee virus and sacbrood Virus) with the honeybee host and the parasitic varroa mite”. Journal of General Virology8 (2005): 2281-2289.
22. Moore MD and Jaykus LA. “Virus-bacteria interactions: implications and potential for the applied and agricultural sciences”. Viruses 2 (2018): 61.
23. Wardwell LH., et al. “Current concepts of the intestinal microbiota and the pathogenesis of infection”. Current Infectious Disease Reports 1 (2011): 28-34.
24. De la Cruz-Peña MJ., et al. “Deciphering the human virome with single-virus genomics and metagenomics”. Viruses3 (2018): 113.
25. Geroges FM and Seleem D. “Oral dysbiosis and systemic diseases”. Frontiers in Dental Medicine 22 (2022): 995423.
26. Sánchez-Pellicer P., et al. “Comparative analysis of gut microbiota in patients with irritable bowel syndrome and healthy controls”. Journal of Clinical Medicine 4 (2025): 1198.
27. Gu Y., et al. “The potential role of gut microbiome in irritable bowel syndrome”. Frontiers in Microbiology 10 (2019): 1894.
28. Banaszak M., et al. “Association between gut dysbiosis and the occurrence of SIBO, LIBO, SIFO and IMO”. Microorganisms 3 (2023): 573.
29. Peterson J., et al. “The NIH Human Microbiome Project. The NIH HMP Working Group”. Genome Research 12 (2009): 2317-2323.
30. Takiishi T., et al. “Intestinal barrier and gut microbiota: shaping our immune responses throughout life”. Tissue Barriers4 (2017): e1373208.
31. Lawrence D., et al. “Phages and human health: more than Idle Hitchhikers”. Viruses 7 (2019): 587.
32. Liévin-Le and Servin AL. “Anti-infective activities of Lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents”. Clinical Microbiology Reviews 2 (2014): 167-199.
33. Jorquera D., et al. “The challenge of controlling foodborne diseases: bacteriophages as a new biotechnological tool”. Revista Chilena de Infectología 6 (2015): 678-688.
34. Loc-Carrillo C and Abedon ST. “Pros and cons of phage therapy”. Bacteriophage2 (2011): 111-114.
35. Howard-Varona C., et al. “Lysogeny in Nature: mechanisms, impact and ecology of temperate phages”. ISME Journal7 (2017): 1511-1520.
36. Cheng YW., et al. “Fecal microbiota transplant decreases mortality in patients with refractory severe or fulminant Clostridioides difficile infection”. Clinical Gastroenterology and Hepatology 10 (2020): 2234-2243.e1.
37. Abdelghafar YA., et al. “Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta-analysis of randomized control trials”. Health Science Reports 5 (2022): e814.
38. Min S., et al. “Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches”. Experimental and Molecular Medicine 52 (2020): 227-237.
39. Caufield T., et al. “Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy Debate”. PLOS Biology 11 (2013): e1001699.
40. Virgin HW. “The virome in mammalian physiology and disease”. Cell1 (2014): 142-150.
41. Osunmakinde CO., et al. “Overview of trends in the application of metagenomic techniques in the analysis of human enteric viral diversity in Africa’s environmental regimes”. Viruses8 (2018): 429.
42. Neil JA and Cadwell K. “The intestinal virome and immunity”. Journal of Immunology 6 (2018): 1615-1624.